Treatment
Acyclovir clinical trials
We’re tracking 6 recruiting studies that include Acyclovir, each written for real people, not researchers, below.
Recruiting studies
- NCT07448844RecruitingPhase 4
Comparing vitamin D3 and acyclovir shots for skin warts
This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.
Rawalpindi, Punjab ProvinceAges 12 years+ - NCT06134492RecruitingPhase 3
Acyclovir for pneumonia patients with HSV-1 on breathing support
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT05589688RecruitingPhase 1
Personalized acyclovir dosing in overweight and obese volunteers
This Phase 1 study tests how to adjust acyclovir dosing based on body weight and kidney function. It includes healthy volunteers across normal weight, overweight, and obesity levels to better understand how the drug moves through the body.
ToulouseAges 18–50 - NCT07341386RecruitingPhase 4
Preventing herpes outbreaks in autoimmune rheumatic diseases
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
São Paulo, São PauloAges 12 years+ - NCT03178149RecruitingPhase 1
Study of a new eye treatment for dry macular degeneration
This Phase 1 trial tests the safety and side effects of ASP7317 in older adults whose central vision is worsening from dry age-related macular degeneration (geographic atrophy). If you qualify, you would receive treatment in the study eye and be closely monitored for about a year.
Phoenix, ArizonaAges 50 years+ - NCT05198570Recruiting
Measuring how acyclovir moves in children with cancer
This study checks how acyclovir behaves in the body when it’s given by mouth or through an IV to children receiving cancer care. It may help doctors better choose doses and monitor the medicine in kids who need prevention or treatment of certain viral infections.
Trieste, TSAges 6 months–18 years
What Acyclovir is being studied for
Conditions with recruiting Acyclovir studies.
Common questions
- Are there clinical trials studying Acyclovir?
- Yes. Clin2 currently lists 6 recruiting studies that include Acyclovir, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Acyclovir trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Acyclovir an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Acyclovir or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.